Open interest in SHIB futures contracts spiked 33%, suggesting increased liquidity and potential for higher volatility. Technical analysis points to potential breakout from descending channel ...
in dogs. Corbus Pharmaceuticals Holdings, Inc announced today the dosing of the first subject in the single ascending dose / multiple ascending dose (SAD/MAD) portion of the Phase 1 trial of CRB ...
Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback